INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molina Healthcare, Inc. - MOH
1. Pomerantz LLP investigates potential securities fraud at Molina Healthcare. 2. Molina's Q2 2025 earnings missed expectations, causing stock price drops. 3. Company lowers full-year guidance by over 10% due to rising medical costs. 4. Stock fell 16.8% after final Q2 results revealed continued financial pressures. 5. Class action claims are being pursued for investor protection.